Recurrent seizures, progressive cognitive decline, Parkinsonism and a calcified brain: is it Fahr's disease?
- Correspondence to Dr Osama S M Amin,
A 34-year-old man developed three generalised seizures over a period of 2 weeks. He had generalised rigidity and mild bilateral symmetrical resting tremor. His deep tendon reflexes were normal with downward planter reflexes. His elder brother noticed that the patient had a progressive cognitive decline over the past few years. He resides in a village and works in a grocery store. His blood tests, including serum calcium, phosphate, alkaline phosphatase and parathyroid hormone, were within their normal reference ranges. His non-contrast CT brain scan reveals widespread symmetrical intracerebral calcification (figures 1 and 2).
Most cases of Fahr's disease come into light during their third to fifth decades of life after demonstrating a variable combination of abnormal movements (dystonia, chorea), Parkinsonism, subcortical type of dementia, seizures (focal and/or generalised) and (uncommonly) pancerebellar dysfunction. The disease results from progressive and bilateral symmetrical calcification of the basal ganglia, thalami, subcortical white matter of the hemispheres and deep cerebellar nuclei; therefore, striatopallidodentate calcinosis is a more precise designation.1 The metabolisms of calcium kinetics and other minerals are normal.
Our patient was taking oral fluoxetine (40 mg/day) which was prescribed by his local general practitioner (GP); the progressive cognitive impairment with generalised hypokinesia (and slow movements) might have prompted the GP to think of a depressive illness. The development of seizures (and subsequent CT brain findings) had uncovered the disease which the patient has.
Fahr's disease, or striatopallidodentate calcinosis, is a rare disease that has protean manifestations with a variable combination of abnormal movements, Parkinsonism, dementia, seizures and cerebellar dysfunction.
Seizures, focal and/or generalised are rare presenting features.
The development of progressive cognitive decline and Parkinsonism in young individuals should always prompt the physician to think of diseases other than depression.
Competing interests None.
Patient consent Obtained.
Provenance and peer review Not commissioned; externally peer reviewed.